Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2677

Actual shortage: 255 (10%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2413 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

24 (9%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-OLMESARTAN 20MG TABLET Resolved 2018-10-22 2020-06-11 65350
TEVA-PRAZOSIN 5MG TABLET Resolved 2018-10-23 2019-04-27 65494
ACT METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65990
ACT METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65993
ACT METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65996
ACT METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65999
TEVA-TELMISARTAN 40MG TABLET Resolved 2018-11-20 2019-04-11 67219
TEVA-TELMISARTAN 40MG TABLET Resolved 2018-11-20 2020-06-04 67222
TEVA-TELMISARTAN 80MG TABLET Resolved 2018-11-20 2020-05-08 67225
TEVA-TELMISARTAN 80MG TABLET Resolved 2018-11-20 2020-05-08 67228
TEVA-TELMISARTAN 80MG TABLET Resolved 2018-11-20 2020-05-14 67231
TEVA-TELMISARTAN HCTZ 12.5MG 80MG TABLET Resolved 2018-11-20 2019-04-27 67234
TEVA-TELMISARTAN HCTZ 12.5MG 80MG TABLET Resolved 2018-11-20 2019-07-15 67237
TEVA-TELMISARTAN HCTZ 12.5MG 80MG TABLET Resolved 2018-11-20 2019-04-27 67240
TEVA-TELMISARTAN HCTZ 25.0MG 80.0MG TABLET Resolved 2018-11-20 2019-03-12 67243
TEVA-TELMISARTAN HCTZ 25.0MG 80.0MG TABLET Resolved 2018-11-20 2019-03-12 67246
TEVA-AMPHETAMINE XR 2.5MG 2.5MG 2.5MG 2.5MG CAPSULE (EXTENDED RELEASE) Resolved 2018-11-30 2019-01-31 68265
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-04 2019-10-17 68569
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-04 2019-10-10 68572
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-04 2020-02-13 68577

Showing 561 to 580 of 2677

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-PIOGLITAZONE 15MG TABLET Discontinued 2018-10-19 2018-10-19 65026
TEVA-PIOGLITAZONE 30MG TABLET Discontinued 2018-10-19 2018-10-19 65030
TEVA-PIOGLITAZONE 45MG TABLET Discontinued 2018-10-19 2018-10-19 65033
TEVA-QUETIAPINE 100MG TABLET Discontinued 2018-10-19 2018-10-19 65036
TEVA-QUETIAPINE 200MG TABLET Discontinued 2018-10-19 2018-10-19 65039
TEVA-QUETIAPINE 25MG TABLET Discontinued 2018-10-19 2018-10-19 65044
TEVA-QUETIAPINE 300MG TABLET Discontinued 2018-10-19 2018-10-19 65047
ACT CLOPIDOGREL Discontinued 2018-10-19 2018-10-19 65065
ACT ZOPICLONE 5MG TABLET Discontinued 2018-10-22 2018-10-22 65191
ACT ZOPICLONE 7.5MG TABLET Discontinued 2018-10-22 2018-10-22 65213
ACT ZOPICLONE 7.5MG TABLET Discontinued 2018-10-22 2018-10-22 65218
ACT TADALAFIL Discontinued 2018-10-22 2018-10-22 65284
ACT TADALAFIL Discontinued 2018-10-22 2018-10-22 65289
ACT VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Discontinued 2018-10-22 2018-10-22 65292
ACT VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Discontinued 2018-10-22 2018-10-22 65295
ACT VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Discontinued 2018-10-22 2018-10-22 65298
ACT VENLAFAXINE XR 150.0MG CAPSULE (EXTENDED RELEASE) Discontinued 2018-10-22 2018-10-22 65305
ACT OXYCODONE CR 5MG TABLET (EXTENDED-RELEASE) Discontinued 2018-10-22 2018-10-22 65328
ACT ETIDROCAL 400MG 500MG TABLET Discontinued 2019-02-21 2019-03-01 76486
TEVA-LISINOPRIL (TYPE P) 5MG TABLET Discontinued 2019-04-11 2019-04-11 81298

Showing 81 to 100 of 250